Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone vs Metformin in Pediatric Type 2 Diabetes
NCT01396564Phase 2Completed
- Sponsor
- Coordinación de Investigación en Salud
- Start
- Oct 2005
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Coordinación de Investigación en Salud. Primary endpoint: Resistin Plasma Levels at 48 weeks. Started Oct 2005; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01396564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01396564.